Aug 06, 2018
Imprimis Pharmaceuticals Announces Second Quarter 2018 Results
Jul 18, 2018
Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018
May 30, 2018
ImprimisRx's Dropless® Steroid and Antibiotic Intravitreal Injection Featured in the Prestigious Journal of Cataract and Refractive Surgery
May 15, 2018
Imprimis Pharmaceuticals Announces First Quarter 2018 Results
May 15, 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Apr 10, 2018
Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & Refractive Surgery Medical Meeting
Mar 27, 2018
Imprimis Pharmaceuticals Issued Composition Patent for Non-Opioid Conscious Sedation Formulation
Mar 08, 2018
Imprimis Pharmaceuticals Announces Fourth Quarter 2017 Results
Mar 07, 2018
Imprimis Pharmaceuticals to Present at 30th Annual ROTH Conference on March 13, 2018
Mar 06, 2018
Imprimis Pharmaceuticals Announces Program for Custom Compounded Ophthalmic Formulations
Feb 15, 2018
Imprimis Pharmaceuticals to Host its Fourth Quarter 2017 Financial Report Conference Call and Webcast on March 8, 2018 at 4:30 p.m. EST
Jan 30, 2018
Imprimis Pharmaceuticals Now Making Available Two Glaucoma Drugs on FDA's Drug Shortage List
Nov 14, 2017
Imprimis Pharmaceuticals Announces Third Quarter 2017 Results
Oct 31, 2017
Imprimis Pharmaceuticals to Host its Third Quarter 2017 Financial Report Conference Call and Webcast on November 14, 2017 at 4:15 p.m. EST
Oct 24, 2017
Imprimis Launches Surface Pharmaceuticals Subsidiary
Oct 19, 2017
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis®
Sep 14, 2017
FDA Curcumin Investigation Supports Imprimis Statement
Sep 11, 2017
Imprimis Releases Statement Regarding Allergan Lawsuit
Sep 07, 2017
Allergan Files Suits Against Imprimis Pharmaceuticals, Inc., Prescriber's Choice, Inc., and Sincerus Florida, LLC
Aug 10, 2017
Imprimis Pharmaceuticals Announces Second Quarter 2017 Financial Results